---
layout: minimal-medicine
nav_exclude: true
title: Poractant Alfa
---

# Poractant Alfa

**Generic Name:** Poractant alfa

**Usage:** Poractant alfa is a synthetic surfactant used to treat respiratory distress syndrome (RDS) in premature infants.  RDS is a condition where the lungs don't produce enough surfactant, a substance that keeps the air sacs in the lungs from collapsing.  Poractant alfa replaces this missing surfactant, allowing the lungs to inflate and function properly.  It is administered via endotracheal tube directly into the baby's lungs.

**Side Effects:**  Side effects can occur, though they are not always common and vary in severity.  Some potential side effects include:

* **Respiratory:** Apnea (temporary cessation of breathing), bradycardia (slow heart rate), desaturation (low blood oxygen levels), increased oxygen requirement, pneumothorax (collapsed lung), air leaks (pneumomediastinum, subcutaneous emphysema), pulmonary hemorrhage.
* **Cardiovascular:** Hypotension (low blood pressure).
* **Gastrointestinal:** Gastric distention.
* **Other:**  Transient increases in body temperature.

It's crucial to note that the severity and frequency of side effects depend on the infant's overall health, gestational age, and other factors. Medical professionals carefully monitor infants receiving poractant alfa.

**How it Works:** Poractant alfa is a complex mixture of phospholipids (primarily phosphatidylcholine) and other surfactant components.  It works by reducing surface tension in the alveoli (tiny air sacs in the lungs).  This prevents alveolar collapse during exhalation, making it easier for the lungs to inflate with each breath.  By improving lung compliance and gas exchange, it helps the infant breathe more easily and improves oxygenation.

**FAQs:**

* **Is poractant alfa safe?**  While generally safe and effective, like all medications, poractant alfa carries risks.  The benefits must be weighed against the potential risks by a healthcare professional.  Close monitoring of the infant is essential.

* **What are the differences between poractant alfa and other surfactant preparations?**  Different surfactant preparations vary slightly in their composition and manufacturing processes.  The choice of a specific surfactant is often based on factors like infant's gestational age, clinical condition, and physician preference.

* **How is poractant alfa administered?** It's administered directly into the lungs via an endotracheal tube by trained medical professionals in a controlled hospital setting.

* **What if my baby experiences side effects?**  Immediate medical attention is necessary if your baby experiences any concerning side effects after receiving poractant alfa.  The healthcare team will monitor your baby closely and take appropriate action.

* **Is poractant alfa used for adults?** No, poractant alfa is specifically indicated for the treatment of RDS in premature infants.  It is not used in adults or older children.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your or your child's health.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.